MLD Foundation is Advancing Clinical Science and MLD Awareness

Dean Suhr, President of the MLD Foundation (MLDfoundation.org) recently talked with Rare Disease Report about some of the many projects the foundation is involved with the improve awareness and treatment options for MLD (metachromatic leukodystrophy)

MLD is a genetic disorder in which patients are missing the enzyme Arylsulfatase-A. This results in demyelination of neurons (i.e., the white matter in the brain) that in turn leads to progressive loss of neuronal dependent functions.